MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Glenmark Pharma
Glenmark Pharma
BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 29, 15:29
357.00
4.45 (1.26%)
VOLUME 62,143
LIVE
NSE
May 29, 15:31
357.95
5.8 (1.65%)
VOLUME 483,109
Management Interviews on Glenmark Pharma
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Glenmark Pharma sees its India business growing at 23-24% 

10.46 am | 11 May 2011 |  Source: CNBC-TV18

Glenn Saldanha, managing director and CEO of Glenmark Pharmaceuticals, in an interview with CNBC-TV18's Udayan Mukherjee and Mitali Mukherjee, said th...

Glenmark confident of US growth despite Tarka issue 

11.40 am | 14 Mar 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Glenn Saldanha, managing director and chief executive officer of Glenmark Pharmaceuticals said,"Tarka is not a major c...

1
Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.